NCT05169645

Brief Summary

Chronic spontaneous urticaria and angioedema (CSUA) is a disease of the skin characterised by hives, swellings or both that last longer than 6 weeks. People with this disease commonly describe poor sleep, reduced quality of life and psychological difficulties such as depression and anxiety. This study seeks to understand relationships between physical activity, sleep and symptoms of urticaria. We are asking individuals with urticaria to wear a fitbit tracker which monitors their physical activity and sleep. Participants also download an app onto their smartphone called Athena CX which is designed by the study team in DCU. The purpose of the app is capture real-time information from participants on mood and any skin symptoms they experience. We will use this information to learn more about possible links between symptoms of urticaria and lifestyle behaviours.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 27, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

February 1, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2023

Completed
Last Updated

December 27, 2021

Status Verified

December 1, 2021

Enrollment Period

7 months

First QC Date

December 13, 2021

Last Update Submit

December 13, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Physical activity

    Step count as measured by fitbit

    Followed for 12 weeks during programme

  • Urticaria symptomatology

    Urticaria control test score

    Followed for 12 weeks during programme

  • Heart rate variability

    Heart rate variability

    Followed for 12 weeks during programme

Study Arms (1)

CSUA patients

CSUA patients

Other: Physical activity monitoring - Symptom monitoring

Interventions

This is an observational study. There is no intervention outside the collection of data from participants. Consenting participants in the study will be provided with a Fitbit activity tracker and asked to wear it for a period of three months. The Fitbit measures: * Physical activity using daily step count * Additional physical activity entries * Heart rate * Sleep quality * Calories burned * Food log Participants will be asked to download an app onto their smart phone entitled Athena CX. This app is designed to capture: * Urticaria symptomatology using the urticaria control test * Symptoms of depression using 2 items from the PHQ 9 * Symptoms of anxiety using two items from the GAD * Short form self-compassion scale

CSUA patients

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Chronic spontaneous urticaria clinic

You may qualify if:

  • Clinical diagnosis of chronic spontaneous urticaria with or without angioedema
  • Urticaria control test score \< 12 indicating poorly controlled urticaria at time of consent
  • Preference to participate in the study
  • In possession of a smartphone

You may not qualify if:

  • Unable or unwilling to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. James's Hospital

Dublin, Ireland

Location

MeSH Terms

Conditions

Chronic Urticaria

Condition Hierarchy (Ancestors)

UrticariaSkin Diseases, VascularSkin DiseasesSkin and Connective Tissue DiseasesHypersensitivity, ImmediateHypersensitivityImmune System DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Niall Conlon

    St. James's Hospital, Ireland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Katie Ridge

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Immunology specialist registrar

Study Record Dates

First Submitted

December 13, 2021

First Posted

December 27, 2021

Study Start

February 1, 2022

Primary Completion

September 1, 2022

Study Completion

February 1, 2023

Last Updated

December 27, 2021

Record last verified: 2021-12

Locations